Tema Neuroscience and Mental Health ETF (MNTL)
NASDAQ: MNTL · Real-Time Price · USD
23.81
+0.01 (0.03%)
At close: Aug 5, 2025, 4:00 PM
23.81
0.00 (0.00%)
After-hours: Aug 5, 2025, 4:15 PM EDT
MNTL Holdings Information
MNTL is an equity ETF with a total of 44 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 10.32%, Regeneron Pharmaceuticals at 8.08%, Alnylam Pharmaceuticals at 7.74%, argenx SE at 5.83%, and Neurocrine Biosciences at 4.89%.
Total Holdings
44
Top 10 Percentage
55.47%
Asset Class
Equity
ETF Category
Health
Assets
10.28M
PE Ratio
20.46
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Incorporated | 10.32% |
2 | REGN | Regeneron Pharmaceuticals, Inc. | 8.08% |
3 | ALNY | Alnylam Pharmaceuticals, Inc. | 7.74% |
4 | ARGX | argenx SE | 5.83% |
5 | NBIX | Neurocrine Biosciences, Inc. | 4.89% |
6 | TEVA | Teva Pharmaceutical Industries Limited | 4.31% |
7 | LLY | Eli Lilly and Company | 4.05% |
8 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.54% |
9 | IONS | Ionis Pharmaceuticals, Inc. | 3.48% |
10 | SYK | Stryker Corporation | 3.22% |
11 | BIIB | Biogen Inc. | 3.21% |
12 | MDT | Medtronic plc | 2.58% |
13 | EBR: UCB | UCB SA | 2.48% |
14 | ACAD | ACADIA Pharmaceuticals Inc. | 2.42% |
15 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.33% |
16 | AXSM | Axsome Therapeutics, Inc. | 2.33% |
17 | DNLI | Denali Therapeutics Inc. | 1.98% |
18 | n/a | US DOLLARS | 1.96% |
19 | RNA | Avidity Biosciences, Inc. | 1.88% |
20 | JAZZ | Jazz Pharmaceuticals plc | 1.88% |
21 | XENE | Xenon Pharmaceuticals Inc. | 1.81% |
22 | DXCM | DexCom, Inc. | 1.72% |
23 | SRRK | Scholar Rock Holding Corporation | 1.71% |
24 | PTCT | PTC Therapeutics, Inc. | 1.58% |
25 | ALKS | Alkermes plc | 1.53% |
As of Aug 1, 2025